Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

A Kinase Inhibitor with Anti-Pim Kinase Activity is a Potent and Selective Cytotoxic Agent Toward Acute Myeloid Leukemia.

Bjørnstad R, Aesoy R, Bruserud Ø, Brenner AK, Giraud F, Dowling TH, Gausdal G, Moreau P, Døskeland SO, Anizon F, Herfindal L.

Mol Cancer Ther. 2019 Mar;18(3):567-578. doi: 10.1158/1535-7163.MCT-17-1234. Epub 2019 Jan 24.

PMID:
30679386
2.

The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia.

Forthun RB, Hinrichs C, Dowling TH, Bruserud Ø, Selheim F.

Curr Pharm Biotechnol. 2016;17(1):6-19. Review.

PMID:
26343130

Supplemental Content

Loading ...
Support Center